The element astatine shows promising properties to use in targeted cancer radiotherapy. Its isotope At-211 has a half-life of 7.2 hours and undergoes alpha-decay into relatively non-toxic products. It can destroy single malignant cells and get out of the system quickly and with minimal side effects…
The element astatine shows promising properties to use in targeted cancer radiotherapy. Its isotope At-211 has a half-life of 7.2 hours and undergoes alpha-decay into relatively non-toxic products. It can destroy single malignant cells and get out of the system quickly and with minimal side effects…
Routine _ab initio_ modeling of heavy-element chemistry with strong relativistic effects remains insufficiently available to a wide community of chemists…
Routine _ab initio_ modeling of heavy-element chemistry with strong relativistic effects remains insufficiently available to a wide community of chemists…
Routine _ab initio_ modeling of heavy-element chemistry with strong relativistic effects remains insufficiently available to a wide community of chemists…
Routine _ab initio_ modeling of heavy-element chemistry with strong relativistic effects remains insufficiently available to a wide community of chemists…
Heavy main group and f-elements have numerous applications in energy, fundamental research, and medicine. Studying their chemistry experimentally has many issues however…
The heaviest halogen astatine is a perfect representation of the difficulties that come with studying heavy elements. However, its prospective application in radiotherapy as a cancer treatment makes the investment in its research worthwhile…